Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Shares Issued (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Shares Issued for 13 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 221.82% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, up 281.74% year-over-year, with the annual reading at $15.9 million for FY2025, 281.74% up from the prior year.
  • Shares Issued hit $2.9 million in Q4 2025 for Corcept Therapeutics, down from $8.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $8.0 million in Q3 2025 to a low of -$982000.0 in Q4 2023.
  • Historically, Shares Issued has averaged $2.1 million across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Shares Issued: soared 741.25% in 2021 and later plummeted 379.02% in 2023.
  • Year by year, Shares Issued stood at $3.0 million in 2021, then crashed by 106.73% to -$205000.0 in 2022, then tumbled by 379.02% to -$982000.0 in 2023, then skyrocketed by 190.53% to $889000.0 in 2024, then skyrocketed by 221.82% to $2.9 million in 2025.
  • Business Quant data shows Shares Issued for CORT at $2.9 million in Q4 2025, $8.0 million in Q3 2025, and $3.2 million in Q2 2025.